新疫苗的剂量探索:免疫刺激/免疫动力学模型的作用
Dose finding for new vaccines: the role for immunostimulation/immunodynamic modelling
摘要:
目前优化疫苗剂量的方法纯粹是基于经验的,而在药物开发领域,剂量确定使用更先进的定量方法来加速决策。将这些已建立的方法应用于疫苗开发领域,可能会减少目前临床试验样本量大、时间长、成本高的问题,并最终具有更好的挽救生命的潜力。我们提出了免疫刺激/免疫动力学(IS/ID)建模领域,旨在将用于药物给药的数学框架转化为优化疫苗剂量决策。类似于PK/PD建模,IS/ID建模方法应用数学模型来描述免疫应答被疫苗接种(IS)刺激的潜在机制以及所得的测量的免疫应答动力学(ID)。为了推进IS/ID建模,需要生成和整理现有数据集和关于疫苗异速生长和剂量依赖动力学的进一步数据,这需要一个协作环境,学术界、工业界、监管机构、政府和非政府机构提供投入,以分享建模专业知识,并将建模者与疫苗数据联系起来。
英文摘要:
Current methods to optimize vaccine dose are purely empirically based, whereas in the drug development field, dosing determinations use far more advanced quantitative methodology to accelerate decision-making. Applying these established methods in the field of vaccine development may reduce the currently large clinical trial sample sizes, long time frames, high costs, and ultimately have a better potential to save lives. We propose the field of immunostimulation/immunodynamic (IS/ID) modelling, which aims to translate mathematical frameworks used for drug dosing towards optimizing vaccine dose decision-making. Analogous to PK/PD modelling, IS/ID modelling approaches apply mathematical models to describe the underlying mechanisms by which the immune response is stimulated by vaccination (IS) and the resulting measured immune response dynamics (ID). To move IS/ID modelling forward, existing datasets and further data on vaccine allometry and dose-dependent dynamics need to be generated and collate, requiring a collaborative environment with input from academia, industry, regulators, governmental and non-governmental agencies to share modelling expertise, and connect modellers to vaccine data.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。